Global Onco-hematology Molecular Testing Supply, Demand and Key Producers, 2023-2029
The global Onco-hematology Molecular Testing market size is expected to reach $ 1159.6 million by 2029, rising at a market growth of 12.0% CAGR during the forecast period (2023-2029).
This report studies the global Onco-hematology Molecular Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Onco-hematology Molecular Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Onco-hematology Molecular Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Onco-hematology Molecular Testing total market, 2018-2029, (USD Million)
Global Onco-hematology Molecular Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Onco-hematology Molecular Testing total market, key domestic companies and share, (USD Million)
Global Onco-hematology Molecular Testing revenue by player and market share 2018-2023, (USD Million)
Global Onco-hematology Molecular Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Onco-hematology Molecular Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Onco-hematology Molecular Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc. and Cepheid, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Onco-hematology Molecular Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Onco-hematology Molecular Testing Market, By Region:
1. How big is the global Onco-hematology Molecular Testing market?
2. What is the demand of the global Onco-hematology Molecular Testing market?
3. What is the year over year growth of the global Onco-hematology Molecular Testing market?
4. What is the total value of the global Onco-hematology Molecular Testing market?
5. Who are the major players in the global Onco-hematology Molecular Testing market?
6. What are the growth factors driving the market demand?
This report studies the global Onco-hematology Molecular Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Onco-hematology Molecular Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Onco-hematology Molecular Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Onco-hematology Molecular Testing total market, 2018-2029, (USD Million)
Global Onco-hematology Molecular Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Onco-hematology Molecular Testing total market, key domestic companies and share, (USD Million)
Global Onco-hematology Molecular Testing revenue by player and market share 2018-2023, (USD Million)
Global Onco-hematology Molecular Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Onco-hematology Molecular Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Onco-hematology Molecular Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc., Illumina, Inc., Invivoscribe, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc. and Cepheid, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Onco-hematology Molecular Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Onco-hematology Molecular Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- qPCR
- dPCR
- Next-Generation Sequencing
- Others
- National Reference Lab / Specialty Lab
- University Hospital
- Community Hospital
- Asusragen, Inc.
- Bio-Rad Laboratories,Inc.
- ICON Plc
- Integrated DNA Technologies, Inc.
- Illumina, Inc.
- Invivoscribe, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Cepheid
1. How big is the global Onco-hematology Molecular Testing market?
2. What is the demand of the global Onco-hematology Molecular Testing market?
3. What is the year over year growth of the global Onco-hematology Molecular Testing market?
4. What is the total value of the global Onco-hematology Molecular Testing market?
5. Who are the major players in the global Onco-hematology Molecular Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Onco-hematology Molecular Testing Introduction
1.2 World Onco-hematology Molecular Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Onco-hematology Molecular Testing Total Market by Region (by Headquarter Location)
1.3.1 World Onco-hematology Molecular Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.3 China Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.4 Europe Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.5 Japan Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.6 South Korea Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.7 ASEAN Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.8 India Onco-hematology Molecular Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Onco-hematology Molecular Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Onco-hematology Molecular Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.2 World Onco-hematology Molecular Testing Consumption Value by Region
2.2.1 World Onco-hematology Molecular Testing Consumption Value by Region (2018-2023)
2.2.2 World Onco-hematology Molecular Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.4 China Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.5 Europe Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.6 Japan Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.7 South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.8 ASEAN Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.9 India Onco-hematology Molecular Testing Consumption Value (2018-2029)
3 WORLD ONCO-HEMATOLOGY MOLECULAR TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Onco-hematology Molecular Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Onco-hematology Molecular Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Onco-hematology Molecular Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Onco-hematology Molecular Testing in 2022
3.3 Onco-hematology Molecular Testing Company Evaluation Quadrant
3.4 Onco-hematology Molecular Testing Market: Overall Company Footprint Analysis
3.4.1 Onco-hematology Molecular Testing Market: Region Footprint
3.4.2 Onco-hematology Molecular Testing Market: Company Product Type Footprint
3.4.3 Onco-hematology Molecular Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Onco-hematology Molecular Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Onco-hematology Molecular Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Onco-hematology Molecular Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Onco-hematology Molecular Testing Consumption Value Comparison
4.2.1 United States VS China: Onco-hematology Molecular Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Onco-hematology Molecular Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Onco-hematology Molecular Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
4.4 China Based Companies Onco-hematology Molecular Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Onco-hematology Molecular Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
4.5 Rest of World Based Onco-hematology Molecular Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Onco-hematology Molecular Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 qPCR
5.2.2 dPCR
5.2.3 Next-Generation Sequencing
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Onco-hematology Molecular Testing Market Size by Type (2018-2023)
5.3.2 World Onco-hematology Molecular Testing Market Size by Type (2024-2029)
5.3.3 World Onco-hematology Molecular Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Onco-hematology Molecular Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 National Reference Lab / Specialty Lab
6.2.2 University Hospital
6.2.3 Community Hospital
6.3 Market Segment by Application
6.3.1 World Onco-hematology Molecular Testing Market Size by Application (2018-2023)
6.3.2 World Onco-hematology Molecular Testing Market Size by Application (2024-2029)
6.3.3 World Onco-hematology Molecular Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Asusragen, Inc.
7.1.1 Asusragen, Inc. Details
7.1.2 Asusragen, Inc. Major Business
7.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Product and Services
7.1.4 Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Asusragen, Inc. Recent Developments/Updates
7.1.6 Asusragen, Inc. Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories,Inc.
7.2.1 Bio-Rad Laboratories,Inc. Details
7.2.2 Bio-Rad Laboratories,Inc. Major Business
7.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Services
7.2.4 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories,Inc. Recent Developments/Updates
7.2.6 Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
7.3 ICON Plc
7.3.1 ICON Plc Details
7.3.2 ICON Plc Major Business
7.3.3 ICON Plc Onco-hematology Molecular Testing Product and Services
7.3.4 ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ICON Plc Recent Developments/Updates
7.3.6 ICON Plc Competitive Strengths & Weaknesses
7.4 Integrated DNA Technologies, Inc.
7.4.1 Integrated DNA Technologies, Inc. Details
7.4.2 Integrated DNA Technologies, Inc. Major Business
7.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Services
7.4.4 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Integrated DNA Technologies, Inc. Recent Developments/Updates
7.4.6 Integrated DNA Technologies, Inc. Competitive Strengths & Weaknesses
7.5 Illumina, Inc.
7.5.1 Illumina, Inc. Details
7.5.2 Illumina, Inc. Major Business
7.5.3 Illumina, Inc. Onco-hematology Molecular Testing Product and Services
7.5.4 Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Illumina, Inc. Recent Developments/Updates
7.5.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.6 Invivoscribe, Inc.
7.6.1 Invivoscribe, Inc. Details
7.6.2 Invivoscribe, Inc. Major Business
7.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Services
7.6.4 Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Invivoscribe, Inc. Recent Developments/Updates
7.6.6 Invivoscribe, Inc. Competitive Strengths & Weaknesses
7.7 QIAGEN N.V.
7.7.1 QIAGEN N.V. Details
7.7.2 QIAGEN N.V. Major Business
7.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Product and Services
7.7.4 QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 QIAGEN N.V. Recent Developments/Updates
7.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Details
7.8.2 Thermo Fisher Scientific, Inc. Major Business
7.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Services
7.8.4 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.9 Cepheid
7.9.1 Cepheid Details
7.9.2 Cepheid Major Business
7.9.3 Cepheid Onco-hematology Molecular Testing Product and Services
7.9.4 Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cepheid Recent Developments/Updates
7.9.6 Cepheid Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Onco-hematology Molecular Testing Industry Chain
8.2 Onco-hematology Molecular Testing Upstream Analysis
8.3 Onco-hematology Molecular Testing Midstream Analysis
8.4 Onco-hematology Molecular Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Onco-hematology Molecular Testing Introduction
1.2 World Onco-hematology Molecular Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Onco-hematology Molecular Testing Total Market by Region (by Headquarter Location)
1.3.1 World Onco-hematology Molecular Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.3 China Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.4 Europe Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.5 Japan Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.6 South Korea Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.7 ASEAN Onco-hematology Molecular Testing Market Size (2018-2029)
1.3.8 India Onco-hematology Molecular Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Onco-hematology Molecular Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Onco-hematology Molecular Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.2 World Onco-hematology Molecular Testing Consumption Value by Region
2.2.1 World Onco-hematology Molecular Testing Consumption Value by Region (2018-2023)
2.2.2 World Onco-hematology Molecular Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.4 China Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.5 Europe Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.6 Japan Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.7 South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.8 ASEAN Onco-hematology Molecular Testing Consumption Value (2018-2029)
2.9 India Onco-hematology Molecular Testing Consumption Value (2018-2029)
3 WORLD ONCO-HEMATOLOGY MOLECULAR TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Onco-hematology Molecular Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Onco-hematology Molecular Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Onco-hematology Molecular Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Onco-hematology Molecular Testing in 2022
3.3 Onco-hematology Molecular Testing Company Evaluation Quadrant
3.4 Onco-hematology Molecular Testing Market: Overall Company Footprint Analysis
3.4.1 Onco-hematology Molecular Testing Market: Region Footprint
3.4.2 Onco-hematology Molecular Testing Market: Company Product Type Footprint
3.4.3 Onco-hematology Molecular Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Onco-hematology Molecular Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Onco-hematology Molecular Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Onco-hematology Molecular Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Onco-hematology Molecular Testing Consumption Value Comparison
4.2.1 United States VS China: Onco-hematology Molecular Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Onco-hematology Molecular Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Onco-hematology Molecular Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
4.4 China Based Companies Onco-hematology Molecular Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Onco-hematology Molecular Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
4.5 Rest of World Based Onco-hematology Molecular Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Onco-hematology Molecular Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 qPCR
5.2.2 dPCR
5.2.3 Next-Generation Sequencing
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Onco-hematology Molecular Testing Market Size by Type (2018-2023)
5.3.2 World Onco-hematology Molecular Testing Market Size by Type (2024-2029)
5.3.3 World Onco-hematology Molecular Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Onco-hematology Molecular Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 National Reference Lab / Specialty Lab
6.2.2 University Hospital
6.2.3 Community Hospital
6.3 Market Segment by Application
6.3.1 World Onco-hematology Molecular Testing Market Size by Application (2018-2023)
6.3.2 World Onco-hematology Molecular Testing Market Size by Application (2024-2029)
6.3.3 World Onco-hematology Molecular Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Asusragen, Inc.
7.1.1 Asusragen, Inc. Details
7.1.2 Asusragen, Inc. Major Business
7.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Product and Services
7.1.4 Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Asusragen, Inc. Recent Developments/Updates
7.1.6 Asusragen, Inc. Competitive Strengths & Weaknesses
7.2 Bio-Rad Laboratories,Inc.
7.2.1 Bio-Rad Laboratories,Inc. Details
7.2.2 Bio-Rad Laboratories,Inc. Major Business
7.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Services
7.2.4 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bio-Rad Laboratories,Inc. Recent Developments/Updates
7.2.6 Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
7.3 ICON Plc
7.3.1 ICON Plc Details
7.3.2 ICON Plc Major Business
7.3.3 ICON Plc Onco-hematology Molecular Testing Product and Services
7.3.4 ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ICON Plc Recent Developments/Updates
7.3.6 ICON Plc Competitive Strengths & Weaknesses
7.4 Integrated DNA Technologies, Inc.
7.4.1 Integrated DNA Technologies, Inc. Details
7.4.2 Integrated DNA Technologies, Inc. Major Business
7.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Services
7.4.4 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Integrated DNA Technologies, Inc. Recent Developments/Updates
7.4.6 Integrated DNA Technologies, Inc. Competitive Strengths & Weaknesses
7.5 Illumina, Inc.
7.5.1 Illumina, Inc. Details
7.5.2 Illumina, Inc. Major Business
7.5.3 Illumina, Inc. Onco-hematology Molecular Testing Product and Services
7.5.4 Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Illumina, Inc. Recent Developments/Updates
7.5.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.6 Invivoscribe, Inc.
7.6.1 Invivoscribe, Inc. Details
7.6.2 Invivoscribe, Inc. Major Business
7.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Services
7.6.4 Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Invivoscribe, Inc. Recent Developments/Updates
7.6.6 Invivoscribe, Inc. Competitive Strengths & Weaknesses
7.7 QIAGEN N.V.
7.7.1 QIAGEN N.V. Details
7.7.2 QIAGEN N.V. Major Business
7.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Product and Services
7.7.4 QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 QIAGEN N.V. Recent Developments/Updates
7.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Details
7.8.2 Thermo Fisher Scientific, Inc. Major Business
7.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Services
7.8.4 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
7.8.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
7.9 Cepheid
7.9.1 Cepheid Details
7.9.2 Cepheid Major Business
7.9.3 Cepheid Onco-hematology Molecular Testing Product and Services
7.9.4 Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cepheid Recent Developments/Updates
7.9.6 Cepheid Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Onco-hematology Molecular Testing Industry Chain
8.2 Onco-hematology Molecular Testing Upstream Analysis
8.3 Onco-hematology Molecular Testing Midstream Analysis
8.4 Onco-hematology Molecular Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Onco-hematology Molecular Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Onco-hematology Molecular Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Onco-hematology Molecular Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Onco-hematology Molecular Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Onco-hematology Molecular Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Onco-hematology Molecular Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Onco-hematology Molecular Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Onco-hematology Molecular Testing Players in 2022
Table 12. World Onco-hematology Molecular Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Onco-hematology Molecular Testing Company Evaluation Quadrant
Table 14. Head Office of Key Onco-hematology Molecular Testing Player
Table 15. Onco-hematology Molecular Testing Market: Company Product Type Footprint
Table 16. Onco-hematology Molecular Testing Market: Company Product Application Footprint
Table 17. Onco-hematology Molecular Testing Mergers & Acquisitions Activity
Table 18. United States VS China Onco-hematology Molecular Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Onco-hematology Molecular Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 23. China Based Onco-hematology Molecular Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 29. World Onco-hematology Molecular Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Onco-hematology Molecular Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Onco-hematology Molecular Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Onco-hematology Molecular Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Onco-hematology Molecular Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Onco-hematology Molecular Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Asusragen, Inc. Basic Information, Area Served and Competitors
Table 36. Asusragen, Inc. Major Business
Table 37. Asusragen, Inc. Onco-hematology Molecular Testing Product and Services
Table 38. Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Asusragen, Inc. Recent Developments/Updates
Table 40. Asusragen, Inc. Competitive Strengths & Weaknesses
Table 41. Bio-Rad Laboratories,Inc. Basic Information, Area Served and Competitors
Table 42. Bio-Rad Laboratories,Inc. Major Business
Table 43. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Services
Table 44. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Laboratories,Inc. Recent Developments/Updates
Table 46. Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
Table 47. ICON Plc Basic Information, Area Served and Competitors
Table 48. ICON Plc Major Business
Table 49. ICON Plc Onco-hematology Molecular Testing Product and Services
Table 50. ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ICON Plc Recent Developments/Updates
Table 52. ICON Plc Competitive Strengths & Weaknesses
Table 53. Integrated DNA Technologies, Inc. Basic Information, Area Served and Competitors
Table 54. Integrated DNA Technologies, Inc. Major Business
Table 55. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Services
Table 56. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Integrated DNA Technologies, Inc. Recent Developments/Updates
Table 58. Integrated DNA Technologies, Inc. Competitive Strengths & Weaknesses
Table 59. Illumina, Inc. Basic Information, Area Served and Competitors
Table 60. Illumina, Inc. Major Business
Table 61. Illumina, Inc. Onco-hematology Molecular Testing Product and Services
Table 62. Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Illumina, Inc. Recent Developments/Updates
Table 64. Illumina, Inc. Competitive Strengths & Weaknesses
Table 65. Invivoscribe, Inc. Basic Information, Area Served and Competitors
Table 66. Invivoscribe, Inc. Major Business
Table 67. Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Services
Table 68. Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Invivoscribe, Inc. Recent Developments/Updates
Table 70. Invivoscribe, Inc. Competitive Strengths & Weaknesses
Table 71. QIAGEN N.V. Basic Information, Area Served and Competitors
Table 72. QIAGEN N.V. Major Business
Table 73. QIAGEN N.V. Onco-hematology Molecular Testing Product and Services
Table 74. QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. QIAGEN N.V. Recent Developments/Updates
Table 76. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific, Inc. Major Business
Table 79. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Services
Table 80. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 82. Cepheid Basic Information, Area Served and Competitors
Table 83. Cepheid Major Business
Table 84. Cepheid Onco-hematology Molecular Testing Product and Services
Table 85. Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Onco-hematology Molecular Testing Upstream (Raw Materials)
Table 87. Onco-hematology Molecular Testing Typical Customers
Table 1. World Onco-hematology Molecular Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Onco-hematology Molecular Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Onco-hematology Molecular Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Onco-hematology Molecular Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Onco-hematology Molecular Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Onco-hematology Molecular Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Onco-hematology Molecular Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Onco-hematology Molecular Testing Players in 2022
Table 12. World Onco-hematology Molecular Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Onco-hematology Molecular Testing Company Evaluation Quadrant
Table 14. Head Office of Key Onco-hematology Molecular Testing Player
Table 15. Onco-hematology Molecular Testing Market: Company Product Type Footprint
Table 16. Onco-hematology Molecular Testing Market: Company Product Application Footprint
Table 17. Onco-hematology Molecular Testing Mergers & Acquisitions Activity
Table 18. United States VS China Onco-hematology Molecular Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Onco-hematology Molecular Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 23. China Based Onco-hematology Molecular Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Onco-hematology Molecular Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Onco-hematology Molecular Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Onco-hematology Molecular Testing Revenue Market Share (2018-2023)
Table 29. World Onco-hematology Molecular Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Onco-hematology Molecular Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Onco-hematology Molecular Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Onco-hematology Molecular Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Onco-hematology Molecular Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Onco-hematology Molecular Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Asusragen, Inc. Basic Information, Area Served and Competitors
Table 36. Asusragen, Inc. Major Business
Table 37. Asusragen, Inc. Onco-hematology Molecular Testing Product and Services
Table 38. Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Asusragen, Inc. Recent Developments/Updates
Table 40. Asusragen, Inc. Competitive Strengths & Weaknesses
Table 41. Bio-Rad Laboratories,Inc. Basic Information, Area Served and Competitors
Table 42. Bio-Rad Laboratories,Inc. Major Business
Table 43. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Services
Table 44. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bio-Rad Laboratories,Inc. Recent Developments/Updates
Table 46. Bio-Rad Laboratories,Inc. Competitive Strengths & Weaknesses
Table 47. ICON Plc Basic Information, Area Served and Competitors
Table 48. ICON Plc Major Business
Table 49. ICON Plc Onco-hematology Molecular Testing Product and Services
Table 50. ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ICON Plc Recent Developments/Updates
Table 52. ICON Plc Competitive Strengths & Weaknesses
Table 53. Integrated DNA Technologies, Inc. Basic Information, Area Served and Competitors
Table 54. Integrated DNA Technologies, Inc. Major Business
Table 55. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Services
Table 56. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Integrated DNA Technologies, Inc. Recent Developments/Updates
Table 58. Integrated DNA Technologies, Inc. Competitive Strengths & Weaknesses
Table 59. Illumina, Inc. Basic Information, Area Served and Competitors
Table 60. Illumina, Inc. Major Business
Table 61. Illumina, Inc. Onco-hematology Molecular Testing Product and Services
Table 62. Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Illumina, Inc. Recent Developments/Updates
Table 64. Illumina, Inc. Competitive Strengths & Weaknesses
Table 65. Invivoscribe, Inc. Basic Information, Area Served and Competitors
Table 66. Invivoscribe, Inc. Major Business
Table 67. Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Services
Table 68. Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Invivoscribe, Inc. Recent Developments/Updates
Table 70. Invivoscribe, Inc. Competitive Strengths & Weaknesses
Table 71. QIAGEN N.V. Basic Information, Area Served and Competitors
Table 72. QIAGEN N.V. Major Business
Table 73. QIAGEN N.V. Onco-hematology Molecular Testing Product and Services
Table 74. QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. QIAGEN N.V. Recent Developments/Updates
Table 76. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 77. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
Table 78. Thermo Fisher Scientific, Inc. Major Business
Table 79. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Services
Table 80. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 82. Cepheid Basic Information, Area Served and Competitors
Table 83. Cepheid Major Business
Table 84. Cepheid Onco-hematology Molecular Testing Product and Services
Table 85. Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Onco-hematology Molecular Testing Upstream (Raw Materials)
Table 87. Onco-hematology Molecular Testing Typical Customers
LIST OF FIGURES
Figure 1. Onco-hematology Molecular Testing Picture
Figure 2. World Onco-hematology Molecular Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Onco-hematology Molecular Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 13. Onco-hematology Molecular Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Onco-hematology Molecular Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Onco-hematology Molecular Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Onco-hematology Molecular Testing Markets in 2022
Figure 27. United States VS China: Onco-hematology Molecular Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Onco-hematology Molecular Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Onco-hematology Molecular Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Onco-hematology Molecular Testing Market Size Market Share by Type in 2022
Figure 31. qPCR
Figure 32. dPCR
Figure 33. Next-Generation Sequencing
Figure 34. Others
Figure 35. World Onco-hematology Molecular Testing Market Size Market Share by Type (2018-2029)
Figure 36. World Onco-hematology Molecular Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Onco-hematology Molecular Testing Market Size Market Share by Application in 2022
Figure 38. National Reference Lab / Specialty Lab
Figure 39. University Hospital
Figure 40. Community Hospital
Figure 41. Onco-hematology Molecular Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Onco-hematology Molecular Testing Picture
Figure 2. World Onco-hematology Molecular Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Onco-hematology Molecular Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Onco-hematology Molecular Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Onco-hematology Molecular Testing Revenue (2018-2029) & (USD Million)
Figure 13. Onco-hematology Molecular Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Onco-hematology Molecular Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Onco-hematology Molecular Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Onco-hematology Molecular Testing Markets in 2022
Figure 27. United States VS China: Onco-hematology Molecular Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Onco-hematology Molecular Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Onco-hematology Molecular Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Onco-hematology Molecular Testing Market Size Market Share by Type in 2022
Figure 31. qPCR
Figure 32. dPCR
Figure 33. Next-Generation Sequencing
Figure 34. Others
Figure 35. World Onco-hematology Molecular Testing Market Size Market Share by Type (2018-2029)
Figure 36. World Onco-hematology Molecular Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Onco-hematology Molecular Testing Market Size Market Share by Application in 2022
Figure 38. National Reference Lab / Specialty Lab
Figure 39. University Hospital
Figure 40. Community Hospital
Figure 41. Onco-hematology Molecular Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
